Table 1.
Study design of [14C]HMB in Harlan Sprague Dawley rats and B6C3F1/N mice.
| Species | Route | Sex | Dose (mg/kg) | Study Duration (h) | End Point |
|---|---|---|---|---|---|
| Rat | Oral Gavage | male | 10, 100, 500 | 24a, 72 | Dose response |
| male | 100 | 2, 72 | Tissue Distribution | ||
| female | 100 | 72 | Sex Difference | ||
| male/female | 10 | 24 | Toxicokinetic Study | ||
| Dermal | male | 10b, c, d, e,f | 72 | Route Difference | |
| male | 0.1b | 72 | Tissue Distribution | ||
| female | 1c, 15c | 72 | Sex difference | ||
| IV | male | 10 | 72 | Route Difference | |
| male | 10 | 6 | Excretion in Bile | ||
| male/female | 10 | 24 | Toxicokinetic Study | ||
| Mouse | Oral Gavage | male | 100, 500 | 72 | Dose Response |
| female | 100 | 72 | Sex Difference | ||
| Dermal | male | 1f, 10f | 72 | Dose Response | |
| male | 10c, f, g | 72 | Route Difference | ||
| female | 10c, f | 72 | Sex difference | ||
| IV | male | 10 | 72 | Route Difference |
Disposition of radioactivity 24 h of following oral gavage administration of 10 mg/kg [14C]HMB in male HSD rats
Light Paraffin Oil,
Lotion,
Coconut oil,
1:1 Ethanol:Coconut Oil,
Ethanol,
Acetone